ENST00000507955.6:n.*1151C>T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000507955.6(DDX41):n.*1151C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000941 in 1,586,982 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.0045   (  2   hom.,  cov: 33) 
 Exomes 𝑓:  0.00056   (  11   hom.  ) 
Consequence
 DDX41
ENST00000507955.6 non_coding_transcript_exon
ENST00000507955.6 non_coding_transcript_exon
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  0.213  
Publications
0 publications found 
Genes affected
 DDX41  (HGNC:18674):  (DEAD-box helicase 41) DEAD box proteins, characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD), are putative RNA helicases. They are implicated in a number of cellular processes involving alteration of RNA secondary structure, such as translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. Based on their distribution patterns, some members of the DEAD box protein family are believed to be involved in embryogenesis, spermatogenesis, and cellular growth and division. The protein encoded by this gene is a member of the DEAD box protein family and interacts with several spliceosomal proteins. In addition, the encoded protein may recognize the bacterial second messengers cyclic di-GMP and cyclic di-AMP, resulting in the induction of genes involved in the innate immune response. [provided by RefSeq, Jan 2017] 
DDX41 Gene-Disease associations (from GenCC):
- DDX41-related hematologic malignancy predisposition syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, ClinGen, Ambry Genetics
 - acromesomelic dysplasiaInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79). 
BP6
Variant 5-177511717-G-A is Benign according to our data. Variant chr5-177511717-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 434911.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00452 (688/152344) while in subpopulation AFR AF = 0.0158 (658/41574). AF 95% confidence interval is 0.0148. There are 2 homozygotes in GnomAd4. There are 337 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. 
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| DDX41 | NM_016222.4  | c.*74C>T | 3_prime_UTR_variant | Exon 17 of 17 | ENST00000330503.12 | NP_057306.2 | ||
| DDX41 | NM_001321732.2  | c.*74C>T | 3_prime_UTR_variant | Exon 16 of 16 | NP_001308661.1 | |||
| DDX41 | NM_001321830.2  | c.*74C>T | 3_prime_UTR_variant | Exon 17 of 17 | NP_001308759.1 | 
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.00453  AC: 689AN: 152226Hom.:  2  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
689
AN: 
152226
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.000561  AC: 805AN: 1434638Hom.:  11  Cov.: 31 AF XY:  0.000470  AC XY: 334AN XY: 710552 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
805
AN: 
1434638
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
334
AN XY: 
710552
show subpopulations 
African (AFR) 
 AF: 
AC: 
659
AN: 
33068
American (AMR) 
 AF: 
AC: 
44
AN: 
43910
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
24916
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39284
South Asian (SAS) 
 AF: 
AC: 
6
AN: 
83906
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
52260
Middle Eastern (MID) 
 AF: 
AC: 
3
AN: 
5658
European-Non Finnish (NFE) 
 AF: 
AC: 
17
AN: 
1092458
Other (OTH) 
 AF: 
AC: 
76
AN: 
59178
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.500 
Heterozygous variant carriers
 0 
 42 
 83 
 125 
 166 
 208 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 24 
 48 
 72 
 96 
 120 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.00452  AC: 688AN: 152344Hom.:  2  Cov.: 33 AF XY:  0.00452  AC XY: 337AN XY: 74500 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
688
AN: 
152344
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
337
AN XY: 
74500
show subpopulations 
African (AFR) 
 AF: 
AC: 
658
AN: 
41574
American (AMR) 
 AF: 
AC: 
20
AN: 
15304
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5192
South Asian (SAS) 
 AF: 
AC: 
3
AN: 
4826
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10632
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
1
AN: 
68022
Other (OTH) 
 AF: 
AC: 
6
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 37 
 73 
 110 
 146 
 183 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 10 
 20 
 30 
 40 
 50 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
6
AN: 
3478
ClinVar
Significance: Benign/Likely benign 
Submissions summary: Benign:3 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
Jun 21, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified    Benign:1 
Jul 06, 2017
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.